In a policy signal that goes beyond routine budgetary allocation, Finance Minister Nirmala Sitharaman outlined a set of measures aimed at strengthening India’s domestic manufacturing depth across electronics, bio pharma and critical minerals. The announcements, made during her speech, point to a broader industrial strategy that combines production incentives with geographic clustering and supply chain security.

At the centre of the announcement is the enhancement of the outlay under the Electronic Components Manufacturing Scheme to ₹40,000 crore. While India has made visible progress in mobile phone assembly and electronics exports over the past few years, a large part of the value addition still rests on imported components such as semiconductors, printed circuit boards, display units and passive components. The revised outlay signals an attempt to address this structural gap by encouraging deeper localisation in the electronics value chain.

Alongside this, Sitharaman proposed the launch of Bio Pharma Shakti with a financial commitment of ₹10,000 crore spread over the next five years. This initiative aims to build capabilities in biotechnology and pharmaceutical innovation, sectors where India has scale in generics but seeks to improve research, advanced manufacturing and value capture.

The third and equally strategic component of the announcement relates to critical minerals and rare earths. The Finance Minister indicated that Tamil Nadu would be supported in developing a rare earth corridor and that states including Odisha, Kerala, Andhra Pradesh and Tamil Nadu would be aided in establishing critical mineral corridors.

These proposals reflect a growing policy recognition that electronics manufacturing, pharmaceutical research and advanced manufacturing ecosystems are deeply linked to access to rare earth elements and critical minerals, many of which are currently sourced from a narrow set of global suppliers.

India’s manufacturing policy has so far focused heavily on end-product assembly under various Production Linked Incentive (PLI) schemes. The new emphasis is on the intermediate layer of the supply chain — electronic components, critical inputs and materials that determine how much value India retains domestically.

The enhanced outlay for electronic components indicates a shift from assembling imported kits to developing a domestic ecosystem that can support large-scale electronics manufacturing. This is particularly important as global electronics supply chains are being reconfigured amid geopolitical tensions and over-reliance on specific countries for inputs.

Similarly, Bio Pharma Shakti marks a move from India’s traditional strength in bulk drug manufacturing and generics to higher-end bio pharma capabilities that require research infrastructure, specialised manufacturing and regulatory support.

The rare earth and critical mineral corridor strategy adds a geographical dimension to this policy shift. By linking specific mineral-rich states with corridor-based development, the government appears to be aiming at building integrated industrial clusters that combine extraction, processing and downstream manufacturing.

India’s electronics export growth story has been impressive in recent years, but analysts frequently highlight that the domestic value addition remains relatively low due to dependence on imported components. A focused push on components manufacturing could significantly increase value retention within the country and reduce vulnerability to global supply disruptions.

In pharmaceuticals and biotechnology, India faces a similar challenge. While it is a global leader in generic drugs, the next phase of growth requires moving up the value chain into biologics, biosimilars and research-driven products. Dedicated funding under Bio Pharma Shakti provides a signal that policy support is now aligning with this ambition.

The emphasis on rare earths and critical minerals is also strategically timed. These minerals are essential for electronics, electric vehicles, renewable energy equipment and defence applications. By supporting corridor development in select states, the government is attempting to build a domestic ecosystem that reduces reliance on imports and strengthens industrial resilience.

Sitharaman’s announcements indicate a coordinated approach linking manufacturing, minerals and advanced research sectors. Rather than treating electronics, pharmaceuticals and mining as separate silos, the policy narrative ties them together through supply chain integration and regional industrial development.

The selection of Tamil Nadu, Odisha, Kerala and Andhra Pradesh also reflects the presence of mineral resources, existing industrial infrastructure and port connectivity, which are crucial for export-oriented manufacturing clusters.

For the electronics manufacturing ecosystem, particularly companies involved in components, sub-assemblies and precision manufacturing, the higher outlay could translate into fresh investment opportunities and policy incentives.

The pharmaceutical and biotech space may see renewed interest in R&D-focused companies and contract research and manufacturing organisations as funding visibility improves over a multi-year horizon.

Mining and mineral processing companies operating in the identified states could benefit from policy attention, especially if corridor development leads to faster clearances, infrastructure creation and logistics support.